Quick Answer
Bluejay Diagnostics, Inc. reported Common Stock Shares Outstanding of 604,534 shares for the year ending 2025.
- Bluejay Diagnostics, Inc. showed an increase of +336.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Bluejay Diagnostics, Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: 10.53 million shares | Q1 2022: 20.15 million shares | Q2 2022: 20.15 million shares | Q3 2022: 20.15 million shares | Q1 2023: 20.46 million shares | Q2 2023: 1.02 million shares | Q3 2023: 1.24 million shares | Q1 2024: 2.69 million shares | Q2 2024: 2.58 million shares | Q3 2024: 17.83 million shares | Q1 2025: 554,012 shares | Q2 2025: 1.49 million shares | Q3 2025: 1.64 million shares.
- Over the full 6 years of available data (2020 to 2025), Bluejay Diagnostics, Inc.'s Common Stock Shares Outstanding has declined by 80.8%.
- Historical annual values: Fiscal year 2025: 604,534 shares | Fiscal year 2024: 138,503 shares | Fiscal year 2023: 3,098 shares | Fiscal year 2022: 1.01 million shares | Fiscal year 2021: 20.11 million shares | Fiscal year 2020: 3.15 million shares.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: